Thomas DL - Search Results

1

Genetic protection against hepatitis B virus conferred by CCR5Delta32: Evidence that CCR5 contributes to viral persistence.

Thio CL, Astemborski J, Bashirova A, Mosbruger T, Greer S, Witt MD, Goedert JJ, Hilgartner M, Majeske A, O'Brien SJ, Thomas DL, Carrington M. Thio CL, et al. Among authors: thomas dl. J Virol. 2007 Jan;81(2):441-5. doi: 10.1128/JVI.01897-06. Epub 2006 Nov 1. J Virol. 2007. PMID: 17079285 Free PMC article.

2

Epidemiology of hepatitis E virus infection in Turkey.

Thomas DL, Mahley RW, Badur S, Palaoglu KE, Quinn TC. Thomas DL, et al. Lancet. 1993 Jun 19;341(8860):1561-2. doi: 10.1016/0140-6736(93)90698-g. Lancet. 1993. PMID: 8099641 Free article.

3

Persistence and clinical significance of hepatitis G virus infections in injecting drug users.

Thomas DL, Nakatsuji Y, Shih JW, Alter HJ, Nelson KE, Astemborski JA, Lyles CM, Vlahov D. Thomas DL, et al. J Infect Dis. 1997 Sep;176(3):586-92. doi: 10.1086/514078. J Infect Dis. 1997. PMID: 9291303

4

Association of antibody to GB virus C (hepatitis G virus) with viral clearance and protection from reinfection.

Thomas DL, Vlahov D, Alter HJ, Hunt JC, Marshall R, Astemborski J, Nelson KE. Thomas DL, et al. J Infect Dis. 1998 Mar;177(3):539-42. doi: 10.1086/514245. J Infect Dis. 1998. PMID: 9498429

5

Perinatal transmission of hepatitis C virus from human immunodeficiency virus type 1-infected mothers. Women and Infants Transmission Study.

Thomas DL, Villano SA, Riester KA, Hershow R, Mofenson LM, Landesman SH, Hollinger FB, Davenny K, Riley L, Diaz C, Tang HB, Quinn TC. Thomas DL, et al. J Infect Dis. 1998 Jun;177(6):1480-8. doi: 10.1086/515315. J Infect Dis. 1998. PMID: 9607823

6

Viral persistence, antibody to E1 and E2, and hypervariable region 1 sequence stability in hepatitis C virus-inoculated chimpanzees.

Bassett SE, Thomas DL, Brasky KM, Lanford RE. Bassett SE, et al. Among authors: thomas dl. J Virol. 1999 Feb;73(2):1118-26. doi: 10.1128/JVI.73.2.1118-1126.1999. J Virol. 1999. PMID: 9882313 Free PMC article.

7

A prospective, community-based evaluation of liver enzymes in individuals with hepatitis C after drug use.

Inglesby TV, Rai R, Astemborski J, Gruskin L, Nelson KE, Vlahov D, Thomas DL. Inglesby TV, et al. Among authors: thomas dl. Hepatology. 1999 Feb;29(2):590-6. doi: 10.1002/hep.510290219. Hepatology. 1999. PMID: 9918940

8

Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection.

Villano SA, Vlahov D, Nelson KE, Cohn S, Thomas DL. Villano SA, et al. Among authors: thomas dl. Hepatology. 1999 Mar;29(3):908-14. doi: 10.1002/hep.510290311. Hepatology. 1999. PMID: 10051497

9

Class II HLA alleles and hepatitis B virus persistence in African Americans.

Thio CL, Carrington M, Marti D, O'Brien SJ, Vlahov D, Nelson KE, Astemborski J, Thomas DL. Thio CL, et al. Among authors: thomas dl. J Infect Dis. 1999 Apr;179(4):1004-6. doi: 10.1086/314684. J Infect Dis. 1999. PMID: 10068598

10

Acute hepatitis C virus structural gene sequences as predictors of persistent viremia: hypervariable region 1 as a decoy.

Ray SC, Wang YM, Laeyendecker O, Ticehurst JR, Villano SA, Thomas DL. Ray SC, et al. Among authors: thomas dl. J Virol. 1999 Apr;73(4):2938-46. doi: 10.1128/JVI.73.4.2938-2946.1999. J Virol. 1999. PMID: 10074143 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

770 results

Search Page

Filters